Low-dose, low-specific activity 131I-metaiodobenzyl guanidine therapy in metastatic pheochromocytoma/sympathetic paraganglioma: Single-center experience from Western India

Low-dose, low-specific activity 131I-metaiodobenzyl guanidine therapy in metastatic pheochromocytoma/sympathetic paraganglioma: Single-center experience from Western India

Introduction: Radionuclide therapy is a promising treatment modality in metastatic pheochromocytoma/paraganglioma (PPGL). There is scarce data on 131I-metaiodobenzyl guanidine (131I-MIBG) therapy from the Indian subcontinent. Hence, we aim to study the safety and effectiveness of low-dose, low-speci...

Full description

Bibliographic Details
Main Authors: Rohit Barnabas, Sanjeet Kumar Jaiswal, Saba Samad Memon, Vijaya Sarathi, Gaurav Malhotra, Priyanka Verma, Virendra A Patil, Anurag R Lila, Nalini S Shah, Tushar R Bandgar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
131i-mibg
low-specific activity
paraganglioma
pheochromocytoma
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2021;volume=25;issue=2;spage=148;epage=159;aulast=Barnabas

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2021;volume=25;issue=2;spage=148;epage=159;aulast=Barnabas

Similar Items